Raedun Clarke

Raedun Clarke is a seasoned professional in the field of immunology with extensive experience in cancer immunotherapy and process development. Currently serving as Senior Director of Process Development at Fate Therapeutics Inc since January 2015, Raedun Clarke has held multiple roles including Director and Associate Director, contributing significantly as the Lead Scientist for the company's iPSC-derived T cell platform. Prior experience includes a position as a Scientist at the McEwen Center for Regenerative Medicine, where Raedun Clarke was a postdoctoral fellow under Dr. Gordon Keller. Raedun Clarke holds a Ph.D. in Immunology from the University of Colorado Health Science Center and a Bachelor of Arts in Biochemistry and Immunology from the University of Colorado at Colorado Springs.